Global Spinal Cord Injury Treatment Market – Industry Trends and Forecast to 2030

Global Spinal Cord Injury Treatment Market, By Injury Type (Complete Spinal Cord Injuries, Partial Spinal Cord Injuries), Treatment (Corticosteroid, Surgery, Spinal Traction, Others), End User (Hospital, Trauma Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2030.

Spinal Cord Injury Treatment Market Analysis and Size

Spinal cord injury treatment involves a combination of medical interventions and rehabilitative therapies. Immediate medical care focuses on stabilizing the spine and preventing further damage. Surgical procedures may be performed to relieve pressure on the spinal cord or repair damaged structures. Rehabilitation aims to improve function, mobility, and quality of life through physical therapy, occupational therapy, and assistive devices. Ongoing research and advancements continue to explore potential therapies, such as stem cell transplantation and neural prosthetics.

Data Bridge Market Research analyses that the global spinal cord injury treatment market which was USD 7.13 billion in 2022, is expected to reach  USD 10.61 billion by 2030, and is expected to undergo a CAGR of 5.10% during the forecast period from 2023 to 2030. “Corticosteroids” dominates the treatment segment of the global spinal cord injury treatment market owing to their greater therapeutic efficacy. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Spinal Cord Injury Treatment Market Scope and Segmentation

Market Definition

Spinal cord injury treatment, involves implementing medical interventions and rehabilitative strategies to address and manage the consequences of spinal cord damage. It encompasses a comprehensive approach that aims to stabilize the injury, prevent further harm, and facilitate recovery and functional improvement. The treatment may include surgical interventions to relieve compression, medication administration for symptom management, rehabilitation therapies to enhance mobility and function, utilization of assistive devices for daily activities, and ongoing medical care to address secondary complications. The primary objective of treating spinal cord injuries is to optimize the affected individuals' quality of life and promote their maximum level of functional independence.

Global Spinal Cord Injury Treatment Market Dynamics

Drivers

• Advances in Neural Regeneration

Ongoing research and breakthroughs in neural regeneration techniques, such as stem cell therapies and gene therapies, hold great promise for spinal cord injury treatment. The potential for regenerating damaged neural tissue and restoring function creates significant opportunities for global market growth.

• Growing Investment in Research and Development

Increasing investments in research and development activities by both public and private sectors are fuelling the growth of the global spinal cord injury treatment market. These investments support the development of new therapies, clinical trials, and innovative technologies, bringing advancements to the forefront of spinal cord injury treatment.

Opportunities

• Pharmaceutical Innovations

The expanding global market for spinal cord injury treatment creates a favorable environment for pharmaceutical companies to invest in research and development of new drugs and therapies. This includes potential breakthroughs in neuroprotective agents, regenerative medicine, and therapies targeting specific aspects of spinal cord repair and regeneration.

• Assistive Devices and Technologies:

The demand for assistive devices and technologies, such as wheelchairs, mobility aids, exoskeletons, and neuroprosthetics, is expected to increase with the growth of the market. This presents opportunities for companies to develop and provide innovative solutions that enhance mobility, independence, and quality of life for individuals with spinal cord injuries.

Restraints/Challenges

• High Treatment Costs

The cost of spinal cord injury treatment, including surgeries, medications, rehabilitation programs, and assistive devices, can be prohibitively expensive. The financial burden on patients and healthcare systems poses a significant challenge to accessing and providing comprehensive care.

• Limited Treatment Options

Despite advancements, there is still no definitive cure for spinal cord injuries. Current treatment options primarily focus on symptom management, functional improvement, and preventing further damage. The limited availability of breakthrough treatments remains a challenge in achieving optimal recovery.

This global spinal cord injury treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global spinal cord injury treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2020, AbbVie has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug and Fast Track designations for elezanumab (ABT-555), an investigational treatment for patients following spinal cord injury.

Global Spinal Cord Injury Treatment Market Scope

The global spinal cord injury treatment market is segmented on the basis of injury type, treatment, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Injury Type

• Complete Spinal Cord Injuries
• Partial Spinal Cord Injuries

Treatment

• Corticosteroid
• Surgery
• Spinal Traction
• Others

End User

• Hospital
• Trauma Centers
• Ambulatory Surgical Centers
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Spinal Cord Injury Treatment Market Regional Analysis/Insights

The global Spinal cord injury treatment Market is analysed and market size insights and trends are provided by country, injury type, treatment, end user and distribution channel as referenced above.

The countries covered in the global spinal cord injury treatment market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherland, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa

North America accounts the largest market share of the global spinal cord injury treatment market due to presence of advanced healthcare treatment options.

Asia-Pacific is expected to account for the largest market share over coming years for the global spinal cord injury treatment market due to increasing cases of spinal cord injuries.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global spinal cord injury treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global spinal cord injury treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global spinal cord injury treatment market. The data is available for historic period 2010-2020.

Competitive Landscape and Global Spinal Cord Injury Treatment Market Share Analysis

The global spinal cord injury treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global spinal cord injury treatment market.

Some of the major players operating in the global spinal cord injury treatment market are:

• Acorda Therapeutics, Inc. (U.S.)
• Asterias Biotherapeutics (U.S.)
• ReNetX Bio. (U.S.)
• BioArctic AB (Sweden)
• BioTime, Inc. (U.S.)
• InVivo Therapeutics (U.S.)
• Kringle Pharma, Inc. (Japan)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• Pharmicell Co. Ltd. (South Korea)
• Vertex Pharmaceuticals Inc. (U.S.)
• Bioaxone (Canada)
• Teva Pharmaceutical Industries Ltd. (Israel)
• AbbVie Inc. (U.S.)
• Dr. Reddy's Laboratories Ltd. (India)
• Zydus Cadila (India)